BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹2.04 Cr | ₹-6.41 Cr | ₹7.64 Cr | ₹-1.63 Cr | ₹-6.68 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹2.04 Cr |
| Mar2024 | ₹-6.41 Cr |
| Mar2023 | ₹7.64 Cr |
| Mar2022 | ₹-1.63 Cr |
| Mar2021 | ₹-6.68 Cr |
How is Net Cash Inflow / Outflow of BAFNA PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.04 Cr | Positive | |
| Mar2024 | ₹-6.41 Cr | Negative | |
| Mar2023 | ₹7.64 Cr | Positive | |
| Mar2022 | ₹-1.63 Cr | Negative | |
| Mar2021 | ₹-6.68 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹521.9 Cr | 4% | 29.9% | 182.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 4% |
29.9% |
182.3% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses